Fundraising Fox

Eikonizo Therapeutics

1 known investors

eikonizo.com ↗

Eikonizo develops small molecule therapeutics targeting neurodegenerative and cardiorenal diseases. The company is focused on creating novel, disease-modifying treatments to improve patient outcomes.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Founders & leadership

Pa
Professor at MGH, Harvard, Martinos Center for Biomedical Imaging

Investors · 1

Mission BiocapitalSan Francisco · $500K – $500K

In the news